Pso p27, a SERPINB3/B4-derived protein, is most likely a common autoantigen in chronic inflammatory diseases

Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 174(2017) vom: 06. Jan., Seite 10-17
1. Verfasser: Iversen, Ole-Jan (VerfasserIn)
Weitere Verfasser: Lysvand, Hilde, Slupphaug, Geir
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2017
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Review Autoimmune diseases Mast cells Pso p27 Psoriasis SERPINB3/B4 Antigens Antigens, Neoplasm Autoantigens mehr... Serpins antigen pso p27 squamous cell carcinoma-related antigen
LEADER 01000naa a22002652 4500
001 NLM26642175X
003 DE-627
005 20231224214505.0
007 cr uuu---uuuuu
008 231224s2017 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2016.11.006  |2 doi 
028 5 2 |a pubmed24n0888.xml 
035 |a (DE-627)NLM26642175X 
035 |a (NLM)27871892 
035 |a (PII)S1521-6616(16)30489-2 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Iversen, Ole-Jan  |e verfasserin  |4 aut 
245 1 0 |a Pso p27, a SERPINB3/B4-derived protein, is most likely a common autoantigen in chronic inflammatory diseases 
264 1 |c 2017 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 13.06.2017 
500 |a Date Revised 06.02.2018 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved. 
520 |a Autoimmune diseases are characterized by chronic inflammatory reactions localized to an organ or organ-system. They are caused by loss of immunologic tolerance toward self-antigens, causing formation of autoantibodies that mistakenly attack their own body. Psoriasis is a chronic inflammatory autoimmune skin disease in which the underlying molecular mechanisms remain elusive. In this review, we present evidence accumulated through more than three decades that the serpin-derived protein Pso p27 is an autoantigen in psoriasis and probably also in other chronic inflammatory diseases. Pso p27 is derived from the serpin molecules SERPINB3 and SERPINB4 through non-canonical cleavage by mast cell chymase. In psoriasis, it is exclusively found in skin lesions and not in uninvolved skin. The serpins are cleaved into three fragments that remain associated as a Pso p27 complex with novel immunogenic properties and increased tendency to form large aggregates compared to native SERPINB3/B4. The amount of Pso p27 is directly correlated to disease activity, and through formation of complement activating immune-complexes, Pso p27 contribute to the inflammation in the skin lesions. SERPINB3/B4 are expressed in skin fibroblasts and keratinocytes, but normally absent in mast cells. Overexpression of the serpins may be induced by inflammation and hypoxia, resulting in mast cell uptake via yet unknown mechanisms. Here the generation and subsequent release of Pso p27 aggregates may promote an inflammatory loop that contributes to the chronicity of psoriasis and other autoimmune diseases 
650 4 |a Journal Article 
650 4 |a Review 
650 4 |a Autoimmune diseases 
650 4 |a Mast cells 
650 4 |a Pso p27 
650 4 |a Psoriasis 
650 4 |a SERPINB3/B4 
650 7 |a Antigens  |2 NLM 
650 7 |a Antigens, Neoplasm  |2 NLM 
650 7 |a Autoantigens  |2 NLM 
650 7 |a Serpins  |2 NLM 
650 7 |a antigen pso p27  |2 NLM 
650 7 |a squamous cell carcinoma-related antigen  |2 NLM 
700 1 |a Lysvand, Hilde  |e verfasserin  |4 aut 
700 1 |a Slupphaug, Geir  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 174(2017) vom: 06. Jan., Seite 10-17  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:174  |g year:2017  |g day:06  |g month:01  |g pages:10-17 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2016.11.006  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 174  |j 2017  |b 06  |c 01  |h 10-17